Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet
Open Access
- 31 January 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 10 (1) , 6-12
- https://doi.org/10.1016/0885-3924(94)00067-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cancer pain: managementThe Lancet, 1992
- Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of lifeJournal of Pain and Symptom Management, 1991
- Cancer pain management according to WHO analgesic guidelinesJournal of Pain and Symptom Management, 1990
- Determination of morphine in human plasma by radioimmunoassay utilising a preliminary liquid—solid extractionJournal of Pharmaceutical and Biomedical Analysis, 1988
- Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unitJournal of Pain and Symptom Management, 1988
- A validation study of the WHO method for cancer pain reliefCancer, 1987
- Steady-State Pharmacokinetics of Controlled Release Oral Morphine Sulphate in Healthy SubjectsClinical Pharmacokinetics, 1986
- PAIN, THE PHYSIOLOGICAL ANTAGONIST OF OPIOID ANALGESICSThe Lancet, 1984
- Morphine metabolism in cancer patients on increasing oral doses‐no evidence for autoinduction or dose‐dependence.British Journal of Clinical Pharmacology, 1983
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978